Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. / Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbæk; Linneberg, Allan.

In: Endocrine, Vol. 50, No. 1, 09.2015, p. 231-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Skaaby, T, Husemoen, LLN, Thuesen, BH & Linneberg, A 2015, 'Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease', Endocrine, vol. 50, no. 1, pp. 231-8. https://doi.org/10.1007/s12020-015-0547-4

APA

Skaaby, T., Husemoen, L. L. N., Thuesen, B. H., & Linneberg, A. (2015). Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine, 50(1), 231-8. https://doi.org/10.1007/s12020-015-0547-4

Vancouver

Skaaby T, Husemoen LLN, Thuesen BH, Linneberg A. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine. 2015 Sep;50(1):231-8. https://doi.org/10.1007/s12020-015-0547-4

Author

Skaaby, Tea ; Husemoen, Lise Lotte Nystrup ; Thuesen, Betina Heinsbæk ; Linneberg, Allan. / Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. In: Endocrine. 2015 ; Vol. 50, No. 1. pp. 231-8.

Bibtex

@article{3a02fae7ce1d4d6197488cd6a1c3c137,
title = "Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease",
abstract = "Beside its traditional role in skeletal health, vitamin D is believed to have multiple immunosuppressant properties, and low vitamin D status has been suggested to be a risk factor in the development of autoimmune disease. We investigated the association between vitamin D status and development of autoimmune disease. We included a total of 12,555 individuals from three population-based studies with measurements of vitamin D status (25-hydroxy vitamin D). We followed the participants by linkage to the Danish National Patient Register (median follow-up time 10.8 years). Relative risks of autoimmune disease were estimated by Cox regression and expressed as hazard ratios, HRs (95 % confidence intervals CIs). There were 525 cases of incident autoimmune disease. The risk for a 10 nmol/l higher vitamin D was: for any autoimmune disease (HR = 0.94 % CI 0.90, 0.98); thyrotoxicosis (HR = 0.83, 95 % CI 0.72, 0.96); type 1 diabetes (HR = 0.95, 95 % CI 0.88, 1.02), multiple sclerosis (HR = 0.89, 95 % CI 0.74, 1.07), iridocyclitis (HR = 1.00, 95 % CI 0.86, 1.17); Crohn's disease (HR = 0.95, 95 % CI 0.80, 1.13), ulcerative colitis (HR = 0.88, 95 % CI 0.75, 1.04); psoriasis vulgaris (HR = 0.99, 95 % CI 0.86, 1.13); seropositive rheumatoid arthritis (HR = 0.97, 95 % CI 0.89, 1.07), and polymyalgia rheumatica (HR = 0.94, 95 % CI 0.83, 1.06). We found statistically significant inverse associations between vitamin D status and development of any autoimmune disease and thyrotoxicosis in particular. Our findings suggest a possible protective role of a higher vitamin D status on autoimmune disease but warrant further studies to clarify causality.",
author = "Tea Skaaby and Husemoen, {Lise Lotte Nystrup} and Thuesen, {Betina Heinsb{\ae}k} and Allan Linneberg",
year = "2015",
month = sep,
doi = "10.1007/s12020-015-0547-4",
language = "English",
volume = "50",
pages = "231--8",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press",
number = "1",

}

RIS

TY - JOUR

T1 - Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease

AU - Skaaby, Tea

AU - Husemoen, Lise Lotte Nystrup

AU - Thuesen, Betina Heinsbæk

AU - Linneberg, Allan

PY - 2015/9

Y1 - 2015/9

N2 - Beside its traditional role in skeletal health, vitamin D is believed to have multiple immunosuppressant properties, and low vitamin D status has been suggested to be a risk factor in the development of autoimmune disease. We investigated the association between vitamin D status and development of autoimmune disease. We included a total of 12,555 individuals from three population-based studies with measurements of vitamin D status (25-hydroxy vitamin D). We followed the participants by linkage to the Danish National Patient Register (median follow-up time 10.8 years). Relative risks of autoimmune disease were estimated by Cox regression and expressed as hazard ratios, HRs (95 % confidence intervals CIs). There were 525 cases of incident autoimmune disease. The risk for a 10 nmol/l higher vitamin D was: for any autoimmune disease (HR = 0.94 % CI 0.90, 0.98); thyrotoxicosis (HR = 0.83, 95 % CI 0.72, 0.96); type 1 diabetes (HR = 0.95, 95 % CI 0.88, 1.02), multiple sclerosis (HR = 0.89, 95 % CI 0.74, 1.07), iridocyclitis (HR = 1.00, 95 % CI 0.86, 1.17); Crohn's disease (HR = 0.95, 95 % CI 0.80, 1.13), ulcerative colitis (HR = 0.88, 95 % CI 0.75, 1.04); psoriasis vulgaris (HR = 0.99, 95 % CI 0.86, 1.13); seropositive rheumatoid arthritis (HR = 0.97, 95 % CI 0.89, 1.07), and polymyalgia rheumatica (HR = 0.94, 95 % CI 0.83, 1.06). We found statistically significant inverse associations between vitamin D status and development of any autoimmune disease and thyrotoxicosis in particular. Our findings suggest a possible protective role of a higher vitamin D status on autoimmune disease but warrant further studies to clarify causality.

AB - Beside its traditional role in skeletal health, vitamin D is believed to have multiple immunosuppressant properties, and low vitamin D status has been suggested to be a risk factor in the development of autoimmune disease. We investigated the association between vitamin D status and development of autoimmune disease. We included a total of 12,555 individuals from three population-based studies with measurements of vitamin D status (25-hydroxy vitamin D). We followed the participants by linkage to the Danish National Patient Register (median follow-up time 10.8 years). Relative risks of autoimmune disease were estimated by Cox regression and expressed as hazard ratios, HRs (95 % confidence intervals CIs). There were 525 cases of incident autoimmune disease. The risk for a 10 nmol/l higher vitamin D was: for any autoimmune disease (HR = 0.94 % CI 0.90, 0.98); thyrotoxicosis (HR = 0.83, 95 % CI 0.72, 0.96); type 1 diabetes (HR = 0.95, 95 % CI 0.88, 1.02), multiple sclerosis (HR = 0.89, 95 % CI 0.74, 1.07), iridocyclitis (HR = 1.00, 95 % CI 0.86, 1.17); Crohn's disease (HR = 0.95, 95 % CI 0.80, 1.13), ulcerative colitis (HR = 0.88, 95 % CI 0.75, 1.04); psoriasis vulgaris (HR = 0.99, 95 % CI 0.86, 1.13); seropositive rheumatoid arthritis (HR = 0.97, 95 % CI 0.89, 1.07), and polymyalgia rheumatica (HR = 0.94, 95 % CI 0.83, 1.06). We found statistically significant inverse associations between vitamin D status and development of any autoimmune disease and thyrotoxicosis in particular. Our findings suggest a possible protective role of a higher vitamin D status on autoimmune disease but warrant further studies to clarify causality.

U2 - 10.1007/s12020-015-0547-4

DO - 10.1007/s12020-015-0547-4

M3 - Journal article

C2 - 25666936

VL - 50

SP - 231

EP - 238

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 1

ER -

ID: 161851088